Davide Diana

Davide Diana

Auto-generated profile, based on publicly available information

Davide Diana

Department of Echocardiography, Royal Brompton & Harefield Hospitals, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 March 2024 in Journal of Nuclear Cardiology
Verified
Journal Article
Closed access
JOJoseph Okafor
Joseph Okafor
RKRajdeep Khattar
Rajdeep Khattar
VKVasileios Kouranos
Vasileios Kouranos
SOShreya Ohri
Shreya Ohri
DDDavide Diana
Davide Diana
KWKshama Wechalekar
Kshama Wechalekar

21 March 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
LGLuca Grancini
Luca Grancini
DDDavide Diana
Davide Diana
ACAlice Centola
Alice Centola
GMGiovanni Monizzi
Giovanni Monizzi
AMAngelo Mastrangelo
Angelo Mastrangelo
AGAlfredo R. Galassi
Alfredo R. Galassi
Background: Primary percutaneous coronary intervention (pPCI) performed for STEMI may be complicated by the “no-reflow” phenomenon. Aims: A super-selective intracoronary injection of saline solution through a thrombus aspiration catheter (SALINE technique), was investigated for the treatment of no-reflow as compared with the standard care of therapy (SCT). Methods: Among the 1471 patients with STEMI undergoing pPCI between May 2015 and June 2020, 168 patients developed no-reflow. Primary endpoints were the incidence of ST-segment resolution (STR) ≥ 70% at 90 min after PCI and the rate of flow restoration (TIMI flow grade 3 with an MBG > 1). The secondary endpoint was the incidence of major adverse cardiac and cerebrovascular events at 3 years follow-up. Results: After propensity score matching analysis, patients treated with SALINE showed STR ≥ 70% in twelve out of the sixteen patients (75.0%), compared to only three patients out of the sixteen in the SCT control group (19.0%), (p < 0.004). SALINE was associated with a higher probability of final TIMI flow grade 3 with an MBG > 1, as shown in fourteen out of sixteen patients (87.5%), as compared to only seven out of sixteen patients in the SCT group (43.8%), (p < 0.03). MACCE at 3 years follow-up occurred in only one patient (6.3%) in the SALINE group, as compared to eight patients (50%) in the SCT group (p = 0.047). Conclusions: The SALINE technique showed to be a safe and effective strategy to reduce “no-reflow” in STEMI patients as assessed by significant STR, improvement of TIMI flow grade, and better 3-year outcomes.

12 July 2022 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
AGAlfredo R. Galassi
Alfredo R. Galassi
GVGiuseppe Vadalà
Giuseppe Vadalà
GTGabriella Testa
Gabriella Testa
SPSebastiano Puglisi
Sebastiano Puglisi
VSVincenzo Sucato
Vincenzo Sucato
GNGiuseppina Novo
Giuseppina Novo

12 March 2021 in Monaldi Archives for Chest Disease
Verified
Journal Article
Open access
PDF file
CNCinzia Nugara
Cinzia Nugara
AVAnnamaria Lo Voi
Annamaria Lo Voi
DDDavide Diana
Davide Diana
SSSilvia Sarullo
Silvia Sarullo
AZAntonino Zarcone
Antonino Zarcone
FSFilippo M. Sarullo
Filippo M. Sarullo
Patent foramen ovale (PFO) is a common abnormality that occurs in about 25% of the adult population. In most cases is a benign finding, but sometimes the communication between the right and the left atria can be a conduit for thrombi.